About Topas Therapeutics
Topas Therapeutics is a company based in Hamburg (Germany) founded in 2016.. Topas Therapeutics has raised $67.46 million across 6 funding rounds from investors including Evotec, Gimv and European Union. The company has 14 employees as of December 31, 2020. Topas Therapeutics operates in a competitive market with competitors including Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.
- Headquarter Hamburg, Germany
- Employees 14 as on 31 Dec, 2020
-
Sectors
TechnologyHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$67.46 M (USD)
in 6 rounds
-
Latest Funding Round
$21.27 M (USD), Series B
Jul 29, 2021
-
Investors
Evotec
& 7 more
-
Employee Count
14
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Topas Therapeutics
Topas Therapeutics has successfully raised a total of $67.46M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $21.27 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $21.3M
-
First Round
First Round
(22 Mar 2016)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Series B - Topas Therapeutics | Valuation |
investors |
|
| Mar, 2021 | Amount | Grant - Topas Therapeutics | Valuation |
investors |
|
| Oct, 2020 | Amount | Series B - Topas Therapeutics | Valuation | Vesalius Biocapital III , BioMedPartners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Topas Therapeutics
Topas Therapeutics has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Evotec, Gimv and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A European life sciences venture capital investor is operated.
|
Founded Year | Domain | Location | |
|
Early to mid stage life sciences-focused VC firm investing in geographies such as Europe
|
Founded Year | Domain | Location | |
|
Healthcare investments are targeted by Boehringer Ingelheim Venture Fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Topas Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Topas Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Topas Therapeutics Comparisons
Competitors of Topas Therapeutics
Topas Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
|
| domain | founded_year | HQ Location |
Small molecule protein degraders are developed for various disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Topas Therapeutics
Frequently Asked Questions about Topas Therapeutics
When was Topas Therapeutics founded?
Topas Therapeutics was founded in 2016.
Where is Topas Therapeutics located?
Topas Therapeutics is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
Is Topas Therapeutics a funded company?
Topas Therapeutics is a funded company, having raised a total of $67.46M across 6 funding rounds to date. The company's 1st funding round was a Series B of $25.77M, raised on Mar 22, 2016.
How many employees does Topas Therapeutics have?
As of Dec 31, 2020, the latest employee count at Topas Therapeutics is 14.
What does Topas Therapeutics do?
Founded in 2016 and based in Hamburg, Germany, nanoparticle-based therapeutics targeting immunology disorders are developed. Operations focus on the biotech sector, with a pipeline that includes TPM 203 for pemphigus vulgaris, TPM 501502 for celiac disease, and interventions for anti-drug immune responses. Research and development activities are centered on advancing these candidates toward clinical applications in immune-related conditions.
Who are the top competitors of Topas Therapeutics?
Topas Therapeutics's top competitors include ADMA Biologics, BioNTech and Vera Therapeutics.
Who are Topas Therapeutics's investors?
Topas Therapeutics has 8 investors. Key investors include Evotec, Gimv, European Union, Vesalius Biocapital, and BioMedPartners.